Denali Advisors LLC bought a new stake in Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX – Free Report ) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,900 shares of the biopharmaceutical company's stock, valued at approximately $200,000. Other hedge funds also recently modified their holdings of the company. FMR LLC raised its holdings in shares of Catalyst Pharmaceuticals by 24.

https://www.dailypolitical.com/2023/09/29/denali-advisors-llc-takes-200000-position-in-catalyst-pharmaceuticals-inc-nasdaqcprx.html

#dailypolitical